Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TyVAC Nepal typhoid vaccine study
ISRCTN43385161Phase 3Completed
- Sponsor
- University of Oxford
- Start
- Nov 2017
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in typhoid fever comparing Vi-TCV arm with MenA control arm (2 arms). Primary endpoint: Efficacy against blood culture-confirmed typhoid fever. Started Nov 2017; status: completed.
02
Drugs
Typbar-TCVMenAfriVac
03
Conditions
typhoid fever
Beyond the preview
Go deeper on ISRCTN43385161.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ISRCTN43385161.